Study Record News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Record. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Record Today - Breaking & Trending Today

3 Agents to Watch for Decompensated Cirrhosis from NASH

Published: September 15, 2023

HepaStem, BIV201, and Albutein are late-stage pipeline agents in development for NASH, focusing specifically on decompensated cirrhosis.

Source: hcplive.com

Related Topics:

United StatesJohn TchelingerianSravani MekaSandra CamprubiPromethera GroupAcute On Chronic Liver FailureEnd Stage Liver DiseaseNorth AmericaAnnounces InitiationBiovie AnnouncesPatient EnrollmentAscites PhaseEncouraging Efficacy DataConduct Pivotal RegistrationalLong Term AdministrationHuman AlbuminSubjects With Decompensated CirrhosisStudy RecordNonalcoholic SteatohepatitisDecompensated Cirrhosis